Treatment of hormone refractory metastatic prostate cancer with Docetaxel __number__ mg/m __number__ every __number__ weeks ( __number__ W) in combination with daily prednisone has been shown to prolong survival and to have the same efficacy in healthy elderly as in younger patients [ __number__ ].